Your browser doesn't support javascript.
loading
Innovative Randomized Phase I Study and Dosing Regimen Selection to Accelerate and Inform Pivotal COVID-19 Trial of Nirmatrelvir.
Singh, Ravi Shankar P; Toussi, Sima S; Hackman, Frances; Chan, Phylinda L; Rao, Rohit; Allen, Richard; Van Eyck, Lien; Pawlak, Sylvester; Kadar, Eugene P; Clark, Frances; Shi, Haihong; Anderson, Annaliesa S; Binks, Michael; Menon, Sandeep; Nucci, Gianluca; Bergman, Arthur.
Affiliation
  • Singh RSP; Pfizer Worldwide Research, Development and Medical, Cambridge, Massachusetts, USA.
  • Toussi SS; Pfizer Worldwide Research, Development and Medical, Pearl River, New York, USA.
  • Hackman F; Pfizer Worldwide Research, Development and Medical, Cambridge, UK.
  • Chan PL; Pfizer Global Product Development, Sandwich, UK.
  • Rao R; Pfizer Worldwide Research, Development and Medical, Cambridge, Massachusetts, USA.
  • Allen R; Pfizer Worldwide Research, Development and Medical, Cambridge, Massachusetts, USA.
  • Van Eyck L; Pfizer Clinical Research Unit, Brussels, Belgium.
  • Pawlak S; Pfizer Clinical Research Unit, New Haven, Connecticut, USA.
  • Kadar EP; Pfizer Worldwide Research, Development and Medical, Groton, Connecticut, USA.
  • Clark F; Pfizer Worldwide Research, Development and Medical, Groton, Connecticut, USA.
  • Shi H; Pfizer Global Product Development, Groton, Connecticut, USA.
  • Anderson AS; Pfizer Worldwide Research, Development and Medical, Pearl River, New York, USA.
  • Binks M; Pfizer Worldwide Research, Development and Medical, Cambridge, Massachusetts, USA.
  • Menon S; Pfizer Worldwide Research, Development and Medical, Cambridge, Massachusetts, USA.
  • Nucci G; Pfizer Worldwide Research, Development and Medical, Cambridge, Massachusetts, USA.
  • Bergman A; Pfizer Worldwide Research, Development and Medical, Cambridge, Massachusetts, USA.
Clin Pharmacol Ther ; 112(1): 101-111, 2022 07.
Article in En | MEDLINE | ID: mdl-35388471
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Clinical_trials Limits: Humans Language: En Journal: Clin Pharmacol Ther Year: 2022 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: COVID-19 Drug Treatment Type of study: Clinical_trials Limits: Humans Language: En Journal: Clin Pharmacol Ther Year: 2022 Type: Article Affiliation country: United States